DiscoverStartupsBiscayne PharmaceuticalsBiscayne Pharmaceuticals Funding Rounds, Valuation & Investors
Developing novel drugs for multiple cancers and other serious disorders1-10 Employees
Biscayne Pharmaceuticals Funding
$4.1M
22 rounds
Biscayne Pharmaceuticals is active in the following markets / industries: biotechnology and medical devices. The company has secured funding across 2 rounds, totaling in an amount of $4.1M. Their most recent funding was raised on May 1, 2014.
Funding Rounds
U
$2600000S
$1500000Investors of Biscayne Pharmaceuticals
Florida Institute for the Commercialization of Public Research
Mesa Verde Venture Partners
GF Securities
Jared Mendel
Co-founded Biscayne Nuero- sold to $SUPN in late 2018. Co-founded Stratford Cresson - investing in the intersection of litigation and healthcare receivables.